Physician profile
Dayron Rodriguez
NPI 1518229046
$8,664.43
in general payments reported to CMS, 2019-2025
39 companies · $1,598 in 2025
The $1,598 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $328 · 2021: $1,110 · 2022: $1,433 · 2023: $2,412 · 2024: $1,185 · 2025: $1,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,077 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,050 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,077.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,050.00 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,713.63 | 2021-2025 | Erleada, Akeega |
| Medtronic, INC. | $1,175.30 | 2023-2024 | Interstim |
| Boston Scientific Corporation | $1,034.20 | 2020-2025 | Ams 700, General - Erectile Dysfunction |
| Coloplast Corp | $711.24 | 2019-2025 | Altis |
| Astellas Pharma US INC | $621.88 | 2021-2023 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $400.35 | 2023-2025 | Gemtesa |
| Tolmar Pharmaceuticals, INC. | $389.39 | 2020-2022 | |
| Caldera Medical, INC | $350.46 | 2022-2024 | Desara |
| Endo Pharmaceuticals INC. | $337.40 | 2020-2023 | Xiaflex |
| Abbvie INC. | $230.50 | 2021-2025 | Lupron Depot |
| Antares Pharma, INC. | $203.36 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Medtronic USA, INC. | $162.85 | 2019 | |
| Verity Pharmaceuticals INC. | $145.14 | 2024-2025 | Tlando, Trelstar |
| Urovant Sciences INC | $123.88 | 2021-2022 | |
| Endo USA, INC. | $101.59 | 2024-2025 | Xiaflex |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayron Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.